Macular Degeneration Trial, Recruiting NCT05454124 Sponsor: University of Alabama at Birmingham Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT05454124
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 89 years old
  • People who have severely reduced vision in both eyes (vision of 20/100 or worse)
  • People who have been diagnosed with Macular Degeneration by an eye specialist (Ophthalmologist)
  • People whose central retina (the macula) shows significantly reduced light sensitivity compared to the surrounding areas, as measured by a specific eye-scanning device called a MAIA
  • People whose medical records show that this level of vision loss has been present for at least 2 years
  • People who live within 50 miles of the trial site

Who may not be able to join:

  • People who have a pacemaker or any ferromagnetic (certain types of) metal implanted anywhere in their body
  • People who have any metal implanted in their head (some limited dental work may be acceptable — confirm with trial site)
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who are hearing-impaired
  • People who weigh more than 300 pounds
  • People whose maximum body width/circumference exceeds 60 inches
  • People who have had a serious head injury in the past
  • People who experience hallucinations or delusions
  • People who have extensive old or colourful tattoos, particularly near the head
  • People who are pregnant
  • People who have braces or a permanent retainer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 205-410-4041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2022
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from Baseline Radial Bias from the Crowding Task after completion of Training at approximately 7 weeks; Change from Baseline Saccadic Precision after Completion of Training at approximately 7 weeks; Change from Baseline Fixation Stability after Completion of Training at approximately 7 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov